All conditions

YOUR CONDITION, EXPLAINED

Leukemia (Except for Chronic Myelogenous Leukemia) VA disability rating & claim guide

The VA rates Leukemia (Except for Chronic Myelogenous Leukemia) under diagnostic code 7703, in 38 CFR § 4.117 (hemic and lymphatic systems), and the schedule provides two evaluation levels for it: 100% and 0%.

DC 7703Hemic and Lymphatic SystemsData last updated September 23, 2026

Free · No account needed

Save your Leukemia (Except for Chronic Myelogenous Leukemia) guide

Email yourself this Leukemia (Except for Chronic Myelogenous Leukemia) guide so the rating criteria, evidence checklist, and preparation tips are easy to find later.

A CLEARER PATH FORWARD

Make sense of your next step.

01Understand the rating02Know what to gather03Plan your preparation
Based on 38 CFR Part 4Free condition guideTake it one step at a time

THE ESSENTIALS

How the VA rates Leukemia (Except for Chronic Myelogenous Leukemia)

DC 7703 is the leukemia code for every leukemia except chronic myelogenous leukemia, which has its own code at DC 7719. It pays 100 percent when there is active disease or during a treatment phase, and it has one 0 percent tier for asymptomatic chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis at Rai Stage 0. What decides most claims under it is not the ladder but the note: the 100 percent continues beyond the cessation of treatment, and six months after that treatment is discontinued a mandatory VA examination determines the rating from then on. If there has been no recurrence, the evaluation moves to the residuals, rated under whatever codes they fall under.

DC 7703 states two evaluations. 100 percent: when there is active disease or during a treatment phase. 0 percent: chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis (MBL), asymptomatic, Rai Stage 0. Between them sits a routing line rather than a tier — otherwise rate residuals under the appropriate diagnostic code(s) — which is where a claim goes once neither of the two criteria applies. Three notes carry the rest. Note (1): a 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures; six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination; any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of 38 CFR 3.105(e); and if there has been no recurrence, rate on residuals. Note (2): evaluate symptomatic chronic lymphocytic leukemia that is at Rai Stage I, II, III, or IV the same as any other leukemia evaluated under this diagnostic code — so the 0 percent tier is confined to Stage 0 and to the asymptomatic case, and a symptomatic CLL is not a lesser claim under this code. Note (3): evaluate residuals of leukemia or leukemia therapy under the appropriate diagnostic code(s), and it names the myeloproliferative disorders separately at diagnostic codes 7704, 7718 and 7719. The exclusion in the code's own title is the thing to check first. Chronic myelogenous leukemia is not rated here: DC 7719 has its own three-tier ladder written about the treatment required, and its Note (1) sends a CML that undergoes leukemic transformation back to this code. 38 CFR 4.31 is not needed for a 0 percent under DC 7703 because the code states one.

Diagnostic code
7703
Rating schedule
38 CFR § 4.117
Schedule levels
100% and 0%
How does the VA choose a rating level?

Which level applies is set by the criteria the evidence meets, not by the diagnosis. Where there is a question as to which of two evaluations applies, 38 CFR § 4.7 assigns the higher one if the disability picture more nearly approximates the criteria required for that rating.

EXPLORE THE PERCENTAGES

Leukemia (Except for Chronic Myelogenous Leukemia) VA rating criteria (DC 7703)

Choose a percentage to see what that level means. Open the full comparison to read all the criteria in one place.

VA RATING100%Leukemia (Except for Chronic Myelogenous Leukemia)

WHAT THIS LEVEL MEANS

Active disease, or any treatment phase. Nothing about cell type or stage changes this while it runs.

Explore 100% criteria & monthly pay
Leukemia (Except for Chronic Myelogenous Leukemia): the criteria for each rating, quoted from 38 CFR § 4.117, DC 7703
Rating38 CFR criteria (quoted)In plain English (Vetrify’s summary)Monthly pay, 2026 (single veteran)
100%

“When there is active disease or during a treatment phase”

Active disease, or any treatment phase. Nothing about cell type or stage changes this while it runs.$3,938.58
0%

“Chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis (MBL), asymptomatic, Rai Stage 0”

Asymptomatic CLL or MBL at Rai Stage 0. The code states this tier rather than leaving it to 38 CFR 4.31.No monthly payment

VA pays on the combined rating, not per condition: each amount is what a veteran with no dependents receives when that percentage is the combined rating, after all separate ratings are combined under 38 CFR 4.25.

These are published rating criteria. Selecting a level does not predict your VA decision.

IN THE REGULATION’S OWN WORDS

What 38 CFR also says about Leukemia (Except for Chronic Myelogenous Leukemia)

The notes 38 CFR Part 4 prints with these criteria, quoted. They govern how the evaluation is made without being a rating level themselves.

  • “Note (1): A 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no recurrence, rate on residuals”DC 7703
  • “Note (2): Evaluate symptomatic chronic lymphocytic leukemia that is at Rai Stage I, II, III, or IV the same as any other leukemia evaluated under this diagnostic code”DC 7703
  • “Note (3): Evaluate residuals of leukemia or leukemia therapy under the appropriate diagnostic code(s). Myeloproliferative Disorders: (Diagnostic Codes 7704, 7718, 7719)”DC 7703

BUILD YOUR EVIDENCE, ONE PIECE AT A TIME

Evidence for your Leukemia (Except for Chronic Myelogenous Leukemia) claim

A long list feels easier when you have a place to start. Use this checklist to see what you have and what still needs gathering.

Your evidence checklist

Check off what you’ve gathered. Progress stays on this page until you leave or refresh.

0 of 4 gathered

THE EXAM FORM

Which DBQ is used for Leukemia (Except for Chronic Myelogenous Leukemia)?

VA's page says: “You can use these forms to submit medical evidence from your health care providers.”

Source: VA: Public Disability Benefits Questionnaires (DBQs), read September 18, 2026.

SMALL DETAILS. BETTER PREPARATION.

Preparing your Leukemia (Except for Chronic Myelogenous Leukemia) claim

Start with the practical tips, then explore the common oversights. You don’t need to work through everything at once.

Practical tips for your claim4 tips
  • 01

    Get the date treatment was discontinued into the file. Every interval this code uses is measured from it.

  • 02

    For chronic lymphocytic leukemia, make sure the Rai stage and the symptomatic or asymptomatic finding are both recorded. They are the whole of the difference between the two stated tiers.

  • 03

    Build the residual claims before the mandatory examination. The schedule says to rate on residuals if there has been no recurrence, and those claims need their own evidence in their own body systems.

  • 04

    Read 38 CFR 3.105(e) alongside Note (1). Any change in evaluation from the mandatory examination or a later one is subject to it.

C&P exam pitfalls to keep in mind4 tips
  • 01

    An examination that reports remission without saying when treatment stopped. The six-month period in Note (1) is measured from discontinuance of treatment, so that date is what the schedule is counting from.

  • 02

    Chronic lymphocytic leukemia recorded without a Rai stage. The 0 percent tier applies only to asymptomatic CLL or MBL at Rai Stage 0, and Note (2) puts every symptomatic stage on the same footing as any other leukemia.

  • 03

    Residuals unexamined because the cancer is in remission. After the mandatory examination the evaluation IS the residuals, and an examination that only reports remission leaves them unrated.

  • 04

    Treatment described without naming its kind. Note (1) lists surgical therapy, radiation therapy, antineoplastic chemotherapy and other therapeutic procedures, and the continuation runs past the cessation of any of them.

Common filing mistakes4 tips
  • 01

    Filing chronic myelogenous leukemia under this code. Its title excludes CML, which is rated under DC 7719 on a three-tier ladder written about the treatment required rather than about active disease.

  • 02

    Treating the 100 percent as permanent. Note (1) makes a VA examination mandatory six months after treatment is discontinued, and 38 CFR 3.105(e) governs the change that examination produces.

  • 03

    Accepting 0 percent for a symptomatic chronic lymphocytic leukemia. Note (2) evaluates a symptomatic CLL at Rai Stage I, II, III or IV the same as any other leukemia under this code.

  • 04

    Closing the claim when the cancer is in remission. The schedule's instruction is to rate on residuals, which is a continuing evaluation rather than the end of one.

When symptoms may first appear2 tips
  • 01

    The schedule states no course of onset for this code. Its top tier is written about a present state — active disease, or a treatment phase — rather than about how the disease arose.

  • 02

    The interval the regulation fixes is six months, counted from discontinuance of treatment to a mandatory VA examination. What that examination evaluates, if there has been no recurrence, is the residuals rather than the leukemia.

LET’S CLEAR A FEW THINGS UP

Common questions about Leukemia (Except for Chronic Myelogenous Leukemia)

Is Leukemia (Except for Chronic Myelogenous Leukemia) a VA-rated disability?

Yes. The VA rates Leukemia (Except for Chronic Myelogenous Leukemia) under VASRD diagnostic code 7703 (Hemic and Lymphatic Systems). DC 7703 is the leukemia code for every leukemia except chronic myelogenous leukemia, which has its own code at DC 7719. It pays 100 percent when there is active disease or during a treatment phase, and it has one 0 percent tier for asymptomatic chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis at Rai Stage 0. What decides most claims under it is not the ladder but the note: the 100 percent continues beyond the cessation of treatment, and six months after that treatment is discontinued a mandatory VA examination determines the rating from then on. If there has been no recurrence, the evaluation moves to the residuals, rated under whatever codes they fall under.

What VA disability rating can I get for Leukemia (Except for Chronic Myelogenous Leukemia)?

Possible VA ratings for Leukemia (Except for Chronic Myelogenous Leukemia) are 100%, 0%. Examples: 100%: When there is active disease or during a treatment phase; 0%: Chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis (MBL), asymptomatic, Rai Stage 0.

What evidence helps prove Leukemia (Except for Chronic Myelogenous Leukemia) for VA disability?

Strong evidence for a Leukemia (Except for Chronic Myelogenous Leukemia) claim includes: The diagnosis, naming the specific leukemia. The code excludes chronic myelogenous leukemia by name, and for chronic lymphocytic leukemia the Rai stage decides whether the 0 percent tier or the 100 percent tier applies; Treatment records with the date treatment was discontinued. Note (1) runs the 100 percent beyond cessation of treatment and starts a six-month period from that date, after which a VA examination is mandatory; For chronic lymphocytic leukemia, a record of the Rai stage and of whether the disease is symptomatic. Note (2) evaluates a symptomatic CLL at Rai Stage I through IV the same as any other leukemia under this code; Records of the residuals, by body system. Note (3) evaluates residuals of leukemia or of leukemia therapy under the appropriate diagnostic codes, which is what the evaluation becomes once there has been no recurrence.

Which DBQ is used for Leukemia (Except for Chronic Myelogenous Leukemia)?

VA's Hematologic and Lymphatic Conditions, Including Leukemia Disability Benefits Questionnaire (DBQ) is on its public list of DBQs. VA's page says: "You can use these forms to submit medical evidence from your health care providers."

What mistakes should veterans avoid when claiming Leukemia (Except for Chronic Myelogenous Leukemia)?

Common pitfalls when filing for Leukemia (Except for Chronic Myelogenous Leukemia): Filing chronic myelogenous leukemia under this code. Its title excludes CML, which is rated under DC 7719 on a three-tier ladder written about the treatment required rather than about active disease; Treating the 100 percent as permanent. Note (1) makes a VA examination mandatory six months after treatment is discontinued, and 38 CFR 3.105(e) governs the change that examination produces; Accepting 0 percent for a symptomatic chronic lymphocytic leukemia. Note (2) evaluates a symptomatic CLL at Rai Stage I, II, III or IV the same as any other leukemia under this code; Closing the claim when the cancer is in remission. The schedule's instruction is to rate on residuals, which is a continuing evaluation rather than the end of one.

Is Leukemia (Except for Chronic Myelogenous Leukemia) a presumptive condition for VA benefits?

Yes, for a veteran who meets a presumption's conditions. 38 CFR 3.309(a) names "Leukemia" among the chronic diseases, for a veteran with 90 days or more of continuous active service in a war period or after December 31, 1946, if it became manifest to a degree of 10 percent or more within the window 38 CFR 3.307(a)(3) sets, one year from separation for most (38 CFR 3.307(a)(1)). Under 38 CFR 3.307(b), "leukemia will be accepted as a chronic disease whether diagnosed as acute or chronic". 38 CFR 3.309(e) names "All chronic B-cell leukemias (including, but not limited to, hairy-cell leukemia and chronic lymphocytic leukemia)" among the diseases associated with herbicide agents, for a veteran exposed to one during service. The regulation presumes that exposure for service in Vietnam, including its offshore waters, from January 9, 1962 to May 7, 1975; in a unit that, as the Department of Defense determined, operated in or near the Korean DMZ where herbicides were applied, from April 1, 1968 to August 31, 1971; or, in the Air Force or Air Force Reserve, regularly and repeatedly aboard C-123 aircraft used to spray herbicides (38 CFR 3.307(a)(6)). The statute, 38 U.S.C. 1116, 1116A and 1116B, also covers U.S. or Royal Thai bases in Thailand, Laos, Mimot or Krek in Cambodia, Guam or American Samoa or their territorial waters, Johnston Atoll or a ship that called there, and the DMZ from September 1, 1967, each in its own period. Only chronic B-cell leukemias are on this list; acute leukemias are not. 38 CFR 3.309(f) names "Adult leukemia" among the diseases associated with the water supply at Camp Lejeune, for a veteran, former reservist or member of the National Guard with at least 30 days of service in total, consecutive or not, at Camp Lejeune or Marine Corps Air Station New River between August 1, 1953 and December 31, 1987 (38 CFR 3.307(a)(7)). 38 CFR 3.309(d) names "Leukemia (other than chronic lymphocytic leukemia)" among the diseases specific to radiation-exposed veterans, whom 38 CFR 3.309(d)(3) defines by radiation-risk activity, such as onsite participation in an atmospheric nuclear test or the occupation of Hiroshima or Nagasaki from August 6, 1945 to July 1, 1946. VA's list of presumptive cancers related to burn pit exposure names "Acute leukemias" and "Chronic leukemias" for a covered veteran of the Gulf War or post-9/11 service (38 U.S.C. 1119(c)): VA's own reading of 38 U.S.C. 1120(b), and by VA's note not a complete list. Each presumption gives way to affirmative evidence to the contrary (38 CFR 3.307(d); 38 U.S.C. 1113).

Is chronic lymphocytic leukemia (CLL) rated at 0 percent?

Only while it is asymptomatic and at Rai Stage 0. DC 7703's 0 percent criterion reads "chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis (MBL), asymptomatic, Rai Stage 0", and Note (2) closes the gap the rest of the way: evaluate symptomatic chronic lymphocytic leukemia that is at Rai Stage I, II, III, or IV the same as any other leukemia evaluated under this diagnostic code. So a symptomatic CLL is not a lesser claim - it reaches the same 100 percent criterion, active disease or a treatment phase, that every other leukemia under this code does. Getting the Rai stage and the symptomatic or asymptomatic finding both into the record is what separates the two tiers.

Why is chronic myelogenous leukemia not rated under DC 7703?

Because the code excludes it in its own title: "Leukemia (except for chronic myelogenous leukemia)". CML is rated under DC 7719, which is the only leukemia code in the schedule with a graduated ladder - 100 percent for a stem cell transplant or continuous myelosuppressive or immunosuppressive therapy, 60 percent for intermittent myelosuppressive therapy or a tyrosine kinase inhibitor or interferon while not in apparent remission, and 30 percent in apparent remission on continuous tyrosine kinase inhibitor therapy. There is one route back: DC 7719's Note (1) says that if the condition undergoes leukemic transformation, evaluate it as leukemia under DC 7703.

Official sources

  1. 38 CFR § 4.117, Schedule of ratings, hemic and lymphatic systems (Diagnostic Code 7703)
  2. 38 CFR § 4.7, higher of two evaluations
  3. 38 CFR 3.309(a), presumptive service connection
  4. 38 CFR 3.309(e), presumptive service connection
  5. 38 CFR 3.309(f), presumptive service connection
  6. 38 CFR 3.309(d), presumptive service connection
  7. VA's list of presumptive cancers related to burn pit exposure, presumptive service connection
  8. VA's list of presumptive cancers related to burn pit exposure, presumptive service connection

Criteria in quotation marks are the regulation’s own words; everything else on this page is Vetrify’s summary of it. The eCFR text is authoritative. See how Vetrify derives its numbers.

How these figures are checked: our methodology and the open dataset.

KEEP YOUR RESEARCH

Is Leukemia (Except for Chronic Myelogenous Leukemia) one of your conditions?

Start a free claim-planning workspace. If Leukemia (Except for Chronic Myelogenous Leukemia) is yours, you can add it to your list there and pick up where you left off. Nothing is added unless you choose it.

Add it to my free plan

PUT THE PIECES TOGETHER

What could your combined rating look like?

See how Leukemia (Except for Chronic Myelogenous Leukemia) combines with your other service-connected conditions using the official VA combined-ratings formula.

Open the free calculator
VA Calc: Disability Pay app icon

VA Calc: Disability Pay

Combine your ratings & see monthly pay on your iPhone · Works offline

Download on theApp Store